Investments in and Advances to Joint Ventures (Tables)

6 Months Ended

Jun. 30, 2022

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	June 30, 2022		December 31, 2021
Current assets	$	232,052	$	246,342
Noncurrent assets		5,996		2,180
Total assets		238,048		248,522
Current liabilities		163,961		175,637
Total liabilities		163,961		175,637
Total joint venture equity	$	74,087	$	72,885

	Three Months Ended				Six Months Ended
	June 30, 2022		June 30, 2021		June 30, 2022		June 30, 2021
Revenue	$	108,089	$	98,245	$	203,623	$	194,869
Costs		98,761		87,097		187,603		173,403
Net income	$	9,328	$	11,148	$	16,020	$	21,466
Net income attributable to noncontrolling interests	$	4,485	$	5,325	$	7,661	$	10,300

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	June 30, 2022		December 31, 2021
Current assets	$	1,670,402	$	1,620,735
Noncurrent assets		523,440		531,261
Total assets		2,193,842		2,151,996
Current liabilities		1,283,227		1,088,985
Noncurrent liabilities		496,487		669,911
Total liabilities		1,779,714		1,758,896
Total joint venture equity	$	414,128	$	393,100
Investments in and advances to unconsolidated joint ventures	$	115,478	$	110,688

	Three Months Ended				Six Months Ended
	June 30, 2022		June 30, 2021		June 30, 2022		June 30, 2021
Revenue	$	594,959	$	736,284	$	979,540	$	972,801
Costs		564,239		696,198		937,525		907,045
Net income	$	30,720	$	40,086	$	42,015	$	65,756
Equity in earnings of unconsolidated joint ventures	$	5,613	$	9,428	$	11,211	$	16,958